Open house pharmaceutical discount agreements for the active substance Imiquimod, ATC D06BB10

Summary

The tender concerns non-exclusive discount agreements for medicines with the active substance Imiquimod (ATC D06BB10) under the open-house model for the period 01 November 2026 to 31 October 2028, with contracts able to be concluded at any time. In the open-house procedure, medicines excluded according to the BfArM list under § 35 para. 5a SGB V (pediatric medicines) are excluded.